Home
Conditions
Hematologic Neoplasms

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

NCT03885947

Conditions: Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Bone Marrow Diseases, +18 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Distracting Through Procedural Pain and Distress

NCT04892160

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +24 more
Locations: Children's Wisconsin Milwaukee, Wisconsin, United States

Medical College of Wisconsin Wauwatosa, Wisconsin, United States

View Trial Details

Completed

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

NCT02500550

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +18 more
Locations: Algemeen Ziekenhuis Sint-Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Universitair Ziekenhuis Gasthuisberg Leuven, Belgium

Centre Hospitalier Universitaire de Liège Liège, Belgium

View Trial Details

Completed

A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer

NCT04419623

Conditions: Blood Cancer, COVID-19, Cancer, +21 more
Locations: Georgia Cancer Center Augusta, Georgia, United States

The Ohio State Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

NCT02129582

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +44 more
Locations: University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

NCT01794299

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +18 more
Locations: Algemeen Ziekenhuis Sint-Jan Bruges, Belgium

Université Libre de Bruxelles - Institute Jules Bordet Brussels, Belgium

Universitair Ziekenhuis Gasthuisberg Leuven, Belgium

Juravinski Hospital and Cancer Centre Hamilton, Ontario, Canada

View Trial Details

Completed

Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D)

NCT04439214

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +23 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT

NCT02528682

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: Trialoffice Haematology-Oncology Nijmegen, Gelderland, Netherlands

View Trial Details

Completed

Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

NCT02805075

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States

View Trial Details

Completed

Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

NCT00886522

Conditions: Graft vs Host Disease, Hematologic Diseases, Hematologic Neoplasms, +5 more
Locations: Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi University Hospital Bologna, Italy

View Trial Details

Hematologic Neoplasms

Hematologic Neoplasms trial results

Related conditions